Literature DB >> 17877602

Self-obtained vaginal swabs for PCR chlamydia testing: a practical alternative.

Sally B Rose1, Beverley A Lawton, Collette Bromhead, E Jane Macdonald, Kim A Lund.   

Abstract

This study shows that given a choice, New Zealand women at high risk for sexually transmitted infections (STI) opt to provide a self-taken vaginal swab over a clinician-taken sample for STI testing. Self-obtained vaginal swabs have previously been shown to have equal sensitivity and specificity to endocervical swabs and greater sensitivity than urine for the detection of Chlamydia trachomatis by polymerase chain reaction (PCR). We suggest that self-obtained vaginal swabs should be a readily available option offered to women for chlamydia testing by PCR in New Zealand.

Entities:  

Mesh:

Year:  2007        PMID: 17877602     DOI: 10.1111/j.1479-828X.2007.00768.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  3 in total

1.  Clinical evaluation of the BD ProbeTec™ Chlamydia trachomatis Qx amplified DNA assay on the BD Viper™ system with XTR™ technology.

Authors:  Stephanie N Taylor; Barbara Van Der Pol; Rebecca Lillis; Edward W Hook; William Lebar; Thomas Davis; Deanna Fuller; Leandro Mena; Paul Fine; Charlotte A Gaydos; David H Martin
Journal:  Sex Transm Dis       Date:  2011-07       Impact factor: 2.830

2.  A quantitative glycogen assay to verify use of self-administered vaginal swabs.

Authors:  Deborah J Anderson; Joseph A Politch; Jeffrey Pudney; Cecilia I Marquez; Margaret C Snead; Christine Mauck
Journal:  Sex Transm Dis       Date:  2012-12       Impact factor: 2.830

3.  To develop and measure the effectiveness and acceptability of a pharmacy-based chlamydia screening intervention in Australia.

Authors:  Sajni Gudka; Lewis Marshall; Alison Creagh; Rhonda M Clifford
Journal:  BMJ Open       Date:  2013-08-17       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.